Forward Pharma
Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs.
Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs.
Forward Pharma, Pioneering new therapies in oncology and autoimmunity through advanced small-molecule pharmaceuticals and targeted antibody drugs. Established in 2015, the company is dedicated to Health Care and Pharmaceutical industries, focusing on developing innovative small-molecule pharmaceuticals and antibody-targeted drugs. Their primary focus is on discovering and advancing pioneering new treatments in the fields of oncology and autoimmunity. Forward Pharma recently received a Series B investment at 14 July 2023 from ZGC Group. This investment is a testament to the potential and promise that the company holds in revolutionizing therapies in these critical medical domains.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | Unknown | 1 | ZGC Group | 14 Jul 2023 |
No recent news or press coverage available for Forward Pharma.
We care about your data, and we'd love to use cookies make your experience better.